
Middle East and Africa Stem Cell Assay Market Report and Forecast 2024-2032
Description
Middle East and Africa Stem Cell Assay Market Report and Forecast 2024-2032
Middle East and Africa Stem Cell Assay Market Report and Forecast 2024-2032
Middle East and Africa Stem Cell Assay Market Size
The global stem cell assay market was valued at USD 6.4 billion in 2023, with the Middle East and Africa holding a significant market share. The market is driven by the rising demand for regenerative medicine. It is expected to grow at a CAGR of 16.3% during the forecast period of 2024-2032, with the values likely to attain USD 19.4 billion by 2032.
Middle East and Africa Stem Cell Assay Market Outlook
- In sub-Saharan Africa , disease burden and mortality from chronic non-communicable diseases have reached an epidemic threshold, which calls for the urgent need for innovative treatment options such as stem cell therapies. Thus, this growing chronic disease burden is likely to fuel the market demand.
- The increasing investment in the establishment and infrastructure development of stem cell facilities is poised to boost the Middle East and Africa stem cell assay market share. For instance, in 2023, the Dubai Healthcare City (DHCC) opened the first-ever good manufacturing practice (GMP), a cleanroom-graded facility in the United Arab Emirates, equipped with the ability to duplicate and manufacture stem cells.
- The market share is also influenced by the rising demand for regenerative medicine and precision treatments along with the growing adoption of technologically advanced stem cell assays and techniques.
A stem cell assay is used to assess the properties and functionality of stem cells. It plays a crucial role in the development of stem cell research and therapy. The expansion of the global stem cell assay market is resulting in the increasing introduction of technologically advanced stem cell assays and techniques, such as automated systems for cell culturing and high-throughput screening methods, in the Middle East and African countries. Further, the rising demand for regenerative medicine and precision treatment approaches to combat the rising disease burden and improve patient outcomes is expected to accelerate the Middle East and Africa stem cell assay market growth in the coming years.
Recent data suggests that chronic non-communicable diseases (CNCDs) are responsible for the death of over 41 million people every year, accounting for 71% of all deaths worldwide. In sub-Saharan Africa, disease burden and mortality from chronic non-communicable diseases have reached an epidemic threshold, which calls for the urgent need for effective interventions including stem cell therapies. Thus, this growing prevalence of such chronic conditions is likely to fuel stem cell research, which is poised to augment the Middle East and Africa stem cell assay market demand for developing and testing new therapies.
One of the major market trends is the rising impetus on stem cell research and the increasing investment in the establishment and infrastructure development of stem cell facilities. For instance, in 2023, the Dubai Healthcare City (DHCC), a designated free zone specializing in healthcare and medical research opened the first-ever good manufacturing practice (GMP), cleanroom-graded facility in the United Arab Emirates. The site is equipped with the ability to duplicate and manufacture stem cells along with storage in the advanced cryogenic bank. Such significant investments in the advancement of stem cell facilities are anticipated to elevate the market value in the forecast period.
Middle East and Africa Stem Cell Assay Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Cell Type
Adult Stem Cells
Human Embryonic Stem Cells
Pluripotent
Market Breakup by Type
Viability/Cytotoxicity Assays
Isolation and Purification Assays
Cell Identification Assays
Proliferation Assays
Differentiation Assays
Function Assays
Apoptosis Assays
Others
Market Breakup by Product and Service
Flow Cytometers
Cell Imaging & Analysis Systems
Microelectrode Arrays
Automated Cell Counters
Kits
Market Breakup by Treatment
Allogeneic Stem Cell Therapy
Autologous Stem Cell Therapy
Syngeneic Stem Cell Therapy
Market Breakup by Application
Regenerative Medicine and Therapy Development
Drug Discovery and Development
Clinical Research
Others
Market Breakup by End User
Biopharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
Market Breakup by Country
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific
- PerkinElmer
- Stemcell Technologies
- Merck
- Bio-Rad Laboratories
- Agilent Technologies
- Promega
- Bio-Techne
- Cell Biolabs
FAQs
- What is the Middle East and Africa stem cell assay market forecast outlook for 2024-2032?
- What are the major factors aiding the Middle East and Africa stem cell assay market demand?
- What are the major Middle East and Africa stem cell assay market trends?
- What is the market segmentation based on the cell type?
- What is the market breakup by type?
- What is the market segmentation based on products and services?
- What are the various treatments available in the market?
- What are the applications of stem cell assay?
- What are the major end users of stem cell assay?
- What is the market segmentation by countries?
- Who are the key players involved in the Middle East and Africa stem cell assay market?
Meta description
The Middle East and Africa stem cell assay market is poised for growth, driven by the expansion of the global market, which was valued at USD 6.4 billion in 2023 and is projected to grow at a CAGR of 13.18% during the forecast period of 2024-2032.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Middle East and Africa Stem Cell Assay Market Overview
- 3.1 Middle East and Africa Stem Cell Assay Market Historical Value (2017-2023)
- 3.2 Middle East and Africa Stem Cell Assay Market Forecast Value (2024-2032)
- 4 Middle East and Africa Stem Cell Assay Market Landscape*
- 4.1 Middle East and Africa Stem Cell Assay: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Middle East and Africa Stem Cell Assay: Product Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Cell Type
- 4.2.3 Analysis by Treatment
- 5 Middle East and Africa Stem Cell Assay Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Analysis
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Middle East and Africa Stem Cell Assay Market Segmentation (2017-2032)
- 6.1 Middle East and Africa Stem Cell Assay Market (2017-2032) by Cell Type
- 6.1.1 Market Overview
- 6.1.2 Adult Stem Cells
- 6.1.3 Human Embryonic Stem Cells
- 6.1.4 Pluripotent
- 6.2 Middle East and Africa Stem Cell Assay Market (2017-2032) by Type
- 6.2.1 Market Overview
- 6.2.2 Viability /Cytotoxicity Assays
- 6.2.3 Isolation & Purification Assays
- 6.2.4 Cell Identification Assays
- 6.2.5 Proliferation Assays
- 6.2.6 Differentiation Assays
- 6.2.7 Function Assays
- 6.2.8 Apoptosis Assays
- 6.2.9 Others
- 6.3 Middle East and Africa Stem Cell Assay Market (2017-2032) by Product & Service
- 6.3.1 Market Overview
- 6.3.2 Flow Cytometers
- 6.3.3 Cell Imaging & Analysis Systems
- 6.3.4 Microelectrode Arrays
- 6.3.5 Automated Cell Counters
- 6.3.6 Kits
- 6.4 Middle East and Africa Stem Cell Assay Market (2017-2032) by Application
- 6.4.1 Market Overview
- 6.4.2 Regenerative Medicine &Therapy Development
- 6.4.3 Drug Discovery & Development
- 6.4.4 Clinical Research
- 6.4.5 Others
- 6.5 Middle East and Africa Stem Cell Assay Market (2017-2032) by End User
- 6.5.1 Market Overview
- 6.5.2 Biopharmaceutical & Biotechnology Companies
- 6.5.3 Academic & Research Institutes
- 6.5.4 Others
- 6.6 Middle East and Africa Stem Cell Assay Market (2017-2032) by Countries
- 6.6.1 Market Overview
- 6.6.2 Saudi Arabia
- 6.6.3 United Arab Emirates
- 6.6.4 Nigeria
- 6.6.5 South Africa
- 6.6.6 Others
- 7 Saudi Arabia of Stem Cell Assay Market (2017-2032)
- 7.1 Saudi Arabia Stem Cell Assay Market (2017-2032) by Cell Type
- 7.1.1 Market Overview
- 7.1.2 Adult Stem Cells
- 7.1.3 Human Embryonic Stem Cells
- 7.1.4 Pluripotent
- 7.2 Saudi Arabia Stem Cell Assay Market (2017-2032) by Type
- 7.2.1 Market Overview
- 7.2.2 Viability /Cytotoxicity Assays
- 7.2.3 Isolation & Purification Assays
- 7.2.4 Cell Identification Assays
- 7.2.5 Proliferation Assays
- 7.2.6 Differentiation Assays
- 7.2.7 Function Assays
- 7.2.8 Apoptosis Assays
- 7.2.9 Others
- 7.3 Saudi Arabia Stem Cell Assay Market (2017-2032) by Product & Service
- 7.3.1 Market Overview
- 7.3.2 Flow Cytometers
- 7.3.3 Cell Imaging & Analysis Systems
- 7.3.4 Microelectrode Arrays
- 7.3.5 Automated Cell Counters
- 7.3.6 Kits
- 7.4 Saudi Arabia Stem Cell Assay Market (2017-2032) by End User
- 7.4.1 Market Overview
- 7.4.2 Biopharmaceutical & Biotechnology Companies
- 7.4.3 Academic & Research Institutes
- 7.4.4 Others
- 7.5 Saudi Arabia Stem Cell Assay Market (2017-2032) by Application
- 7.5.1 Market Overview
- 7.5.2 Regenerative Medicine &Therapy Development
- 7.5.3 Drug Discovery & Development
- 7.5.4 Clinical Research
- 7.5.5 Others
- 8 United Arab Emirates Stem Cell Assay Market (2017-2032)
- 8.1 United Arab Emirates Stem Cell Assay Market (2017-2032) by Cell Type
- 8.1.1 Market Overview
- 8.1.2 Adult Stem Cells
- 8.1.3 Human Embryonic Stem Cells
- 8.1.4 Pluripotent
- 8.2 United Arab Emirates Stem Cell Assay Market (2017-2032) by Type
- 8.2.1 Market Overview
- 8.2.2 Viability /Cytotoxicity Assays
- 8.2.3 Isolation & Purification Assays
- 8.2.4 Cell Identification Assays
- 8.2.5 Proliferation Assays
- 8.2.6 Differentiation Assays
- 8.2.7 Function Assays
- 8.2.8 Apoptosis Assays
- 8.2.9 Others
- 8.3 United Arab Emirates Stem Cell Assay Market (2017-2032) by Product & Service
- 8.3.1 Market Overview
- 8.3.2 Flow Cytometers
- 8.3.3 Cell Imaging & Analysis Systems
- 8.3.4 Microelectrode Arrays
- 8.3.5 Automated Cell Counters
- 8.3.6 Kits
- 8.4 United Arab Emirates Stem Cell Assay Market (2017-2032) by End User
- 8.4.1 Market Overview
- 8.4.2 Biopharmaceutical & Biotechnology Companies
- 8.4.3 Academic & Research Institutes
- 8.4.4 Others
- 8.5 United Arab Emirates Stem Cell Assay Market (2017-2032) by Application
- 8.5.1 Market Overview
- 8.5.2 Regenerative Medicine &Therapy Development
- 8.5.3 Drug Discovery & Development
- 8.5.4 Clinical Research
- 9 Nigeria Stem Cell Assay Market (2017-2032)
- 9.1 Nigeria Stem Cell Assay Market (2017-2032) by Cell Type
- 9.1.1 Market Overview
- 9.1.2 Adult Stem Cells
- 9.1.3 Human Embryonic Stem Cells
- 9.1.4 Pluripotent
- 9.2 Nigeria Stem Cell Assay Market (2017-2032) by Type
- 9.2.1 Market Overview
- 9.2.2 Viability /Cytotoxicity Assays
- 9.2.3 Isolation & Purification Assays
- 9.2.4 Cell Identification Assays
- 9.2.5 Proliferation Assays
- 9.2.6 Differentiation Assays
- 9.2.7 Function Assays
- 9.2.8 Apoptosis Assays
- 9.2.9 Others
- 9.3 Nigeria Stem Cell Assay Market (2017-2032) by Product & Service
- 9.3.1 Market Overview
- 9.3.2 Flow Cytometers
- 9.3.3 Cell Imaging & Analysis Systems
- 9.3.4 Microelectrode Arrays
- 9.3.5 Automated Cell Counters
- 9.3.6 Kits
- 9.4 Nigeria Stem Cell Assay Market (2017-2032) by End User
- 9.4.1 Market Overview
- 9.4.2 Biopharmaceutical & Biotechnology Companies
- 9.4.3 Academic & Research Institutes
- 9.4.4 Others
- 9.5 Nigeria Stem Cell Assay Market (2017-2032) by Application
- 9.5.1 Market Overview
- 9.5.2 Regenerative Medicine &Therapy Development
- 9.5.3 Drug Discovery & Development
- 9.5.4 Clinical Research
- 9.5.5 Others
- 10 South Africa Stem Cell Assay Market (2017-2032)
- 10.1 South Africa Stem Cell Assay Market (2017-2032) by Cell Type
- 10.1.1 Market Overview
- 10.1.2 Adult Stem Cells
- 10.1.3 Human Embryonic Stem Cells
- 10.1.4 Pluripotent
- 10.2 South Africa Stem Cell Assay Market (2017-2032) by Type
- 10.2.1 Market Overview
- 10.2.2 Viability /Cytotoxicity Assays
- 10.2.3 Isolation & Purification Assays
- 10.2.4 Cell Identification Assays
- 10.2.5 Proliferation Assays
- 10.2.6 Differentiation Assays
- 10.2.7 Function Assays
- 10.2.8 Apoptosis Assays
- 10.2.9 Others
- 10.3 South Africa Stem Cell Assay Market (2017-2032) by Product & Service
- 10.3.1 Market Overview
- 10.3.2 Flow Cytometers
- 10.3.3 Cell Imaging & Analysis Systems
- 10.3.4 Microelectrode Arrays
- 10.3.5 Automated Cell Counters
- 10.3.6 Kits
- 10.4 South Africa Stem Cell Assay Market (2017-2032) by End User
- 10.4.1 Market Overview
- 10.4.2 Biopharmaceutical & Biotechnology Companies
- 10.4.3 Academic & Research Institutes
- 10.4.4 Others
- 10.5 South Africa Stem Cell Assay Market (2017-2032) by Application
- 10.5.1 Market Overview
- 10.5.2 Regenerative Medicine &Therapy Development
- 10.5.3 Drug Discovery & Development
- 10.5.4 Clinical Research
- 10.5.5 Others
- 11 Regulatory Framework
- 12 Funding and Investment Analysis
- 12.1 Analysis by Funding Instances
- 12.2 Analysis by Type of Funding
- 12.3 Analysis by Funding Amount
- 12.4 Analysis by Leading Players
- 12.5 Analysis by Leading Investors
- 12.6 Analysis by Geography
- 13 Partnership and Collaborations Analysis
- 13.1 Analysis by Partnership Instances
- 13.2 Analysis by Type of Partnership
- 13.3 Analysis by Leading Players
- 13.4 Analysis by Geography
- 14 Supplier Landscape
- 14.1 Market Share by Top 5 Companies
- 14.2 Thermo Fisher Scientific
- 14.2.1 Financial Analysis
- 14.2.2 Product Portfolio
- 14.2.3 Demographic Reach and Achievements
- 14.2.4 Mergers and Acquisitions
- 14.2.5 Certifications
- 14.3 PerkinElmer
- 14.3.1 Financial Analysis
- 14.3.2 Product Portfolio
- 14.3.3 Demographic Reach and Achievements
- 14.3.4 Mergers and Acquisitions
- 14.3.5 Certifications
- 14.4 Stemcell Technologies
- 14.4.1 Financial Analysis
- 14.4.2 Product Portfolio
- 14.4.3 Demographic Reach and Achievements
- 14.4.4 Mergers and Acquisitions
- 14.4.5 Certifications
- 14.5 Merck
- 14.5.1 Financial Analysis
- 14.5.2 Product Portfolio
- 14.5.3 Demographic Reach and Achievements
- 14.5.4 Mergers and Acquisitions
- 14.5.5 Certifications
- 14.6 Bio-Rad Laboratories
- 14.6.1 Financial Analysis
- 14.6.2 Product Portfolio
- 14.6.3 Demographic Reach and Achievements
- 14.6.4 Mergers and Acquisitions
- 14.6.5 Certifications
- 14.7 Agilent Technologies
- 14.7.1 Financial Analysis
- 14.7.2 Product Portfolio
- 14.7.3 Demographic Reach and Achievements
- 14.7.4 Mergers and Acquisitions
- 14.7.5 Certifications
- 14.8 Promega
- 14.8.1 Financial Analysis
- 14.8.2 Product Portfolio
- 14.8.3 Demographic Reach and Achievements
- 14.8.4 Mergers and Acquisitions
- 14.8.5 Certifications
- 14.9 Bio-Techne
- 14.9.1 Financial Analysis
- 14.9.2 Product Portfolio
- 14.9.3 Demographic Reach and Achievements
- 14.9.4 Mergers and Acquisitions
- 14.9.5 Certifications
- 14.10 Cell Biolabs
- 14.10.1 Financial Analysis
- 14.10.2 Product Portfolio
- 14.10.3 Demographic Reach and Achievements
- 14.10.4 Mergers and Acquisitions
- 14.10.5 Certifications
- 15 Middle East and Africa Stem Cell Assay Market – Distribution Model (Additional Insight)
- 15.1 Overview
- 15.2 Potential Distributors
- 15.3 Key Parameters for Distribution Partner Assessment
- 16 Key Opinion Leaders ( KOL) Insights (Additional Insight)
- 17 Company Competitiveness Analysis (Additional Insight)
- 17.1 Very Small Companies
- 17.2 Small Companies
- 17.3 Mid-Sized Companies
- 17.4 Large Companies
- 17.5 Very Large Companies
- 18 Payment Methods (Additional Insight)
- 18.1 Government Funded
- 18.2 Private Insurance
- 18.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.